Garlic
polysaccharides are great potential agents because of their
anti-inflammation, antioxidation, and immunomodulation properties.
However, few studies have reported their anti-inflammatory effects
on improving the colon system and corresponding intestinal microbiota.
Herein, a water-soluble garlic polysaccharide (WSGP) was extracted
from Jinxiang garlic to evaluate its effects on ameliorating dextran
sulfate sodium (DSS)-induced colitis in a mouse model. The results
showed that (1) after administration of the WSGP (200 or 400 mg/kg/day),
the feed intake, body weight, and colon length of colitic mice were
increased, while the disease activity index and the histological score
of colitic mice were decreased; (2) the WSGP reduced the colonic tissue
damage and inhibited the expression of inflammatory factors (interleukin
6, interleukin 1 beta , and tumor necrosis factor alpha); and (3)
the WSGP enhanced the production of short-chain fatty acids and improved
the composition of intestinal microbiota. The key microorganisms,
including Muribaculaceae, Lachnospiraceae, Lachnospiraceae_NK4A136_group, Mucispirillum, Helicobacter, Ruminococcus_1, and Ruminiclostridium_5, were identified to be associated with inflammatory bowel diseases.
Taken together, this study proved that WSGP supplementation could
alleviate DSS-induced colitis by improving mucosal barriers, blocking
proinflammatory cytokines, and modulating gut microbiota.